Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy
- 1 January 2004
- journal article
- research article
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 9 (1-3) , 565-574
- https://doi.org/10.2741/1257
Abstract
Diabetes markedly raises the risk of microvascular and macrovascular disease, the major contributors to higher morbidity and mortality in this increasingly prevalent disorder. Oxidative stress has been postulated as one major contributor to long-term diabetic complications. However, there is considerable controversy regarding the nature, magnitude, and mechanisms of oxidative stress in the diabetic state. Although products of glycoxidation and lipoxidation are elevated in plasma and tissue from humans suffering from diabetes, the exact relationships among hyperglycemia, the diabetic state, and oxidative stress are undetermined. This review focuses on proposed mechanisms for increasing oxidative stress in diabetes, the relationship of oxidant production to hyperglycemia, the contribution of reactive carbonyl compounds that accumulate in the diabetic state to tissue injury, and the potential role of lipids in producing oxidants. Current evidence argues against a generalized increase in oxidative stress in human diabetes, at least in the extracellular milieu. Instead, reactive intermediates generated in certain microenvironments might promote oxidative stress by unique pathways. Thus, many issues need to be addressed, including the suitability of antioxidants for preventing the clinical sequelae of diabetes.Keywords
This publication has 22 references indexed in Scilit:
- Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathyNature Medicine, 2003
- A Post-Amadori Inhibitor Pyridoxamine Also Inhibits Chemical Modification of Proteins by Scavenging Carbonyl Intermediates of Carbohydrate and Lipid DegradationJournal of Biological Chemistry, 2002
- Biochemistry and molecular cell biology of diabetic complicationsNature, 2001
- MICROVASCULAR COMPLICATIONSEndocrinology and Metabolism Clinics of North America, 2001
- A hydroxyl radical–like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular diseaseJournal of Clinical Investigation, 2001
- Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.Diabetes Care, 1999
- Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (α-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II)Free Radical Research, 1999
- Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.Diabetes, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Oxygen Metabolism and the Toxic Properties of PhagocytesAnnals of Internal Medicine, 1980